Business · 17/07/2024Updated: 10/17/2026 · 1 min read
FDA Approves VYVGART HYTRULO with Rare Pediatric Disease Priority Review Voucher
Summary
The FDA has approved VYVGART HYTRULO, a product redeeming a priority review voucher, following a review of its supplemental application submitted on June 21, 2024.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →